Serina Therapeutics (SER) Short term Debt (2017 - 2025)
Serina Therapeutics (SER) posted Short term Debt of $2.9 million for Q3 2025, down 72.4% sequentially from $10.5 million in Q3 2024, and down 72.4% YoY from $10.5 million in Q3 2024.
Serina Therapeutics (SER) Short term Debt (2017 - 2025) Analysis & Trends
Serina Therapeutics has reported Short term Debt for 9 years, with the latest figure at $2.9 million in Q3 2025.
- Quarterly Short term Debt fell 72.4% year-over-year to $2.9 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $2.9 million (down 72.4% YoY) and the FY2022 annual result came in at $7.6 million, up 7.09% from the prior year.
- Short term Debt fell to $2.9 million in Q3 2025 per SER's latest filing, from $10.5 million in the prior quarter.
- Over five years, Short term Debt peaked at $22.9 million in Q2 2023 and troughed at $59000.0 in Q3 2022.
- A 5-year average of $7.8 million and a median of $7.0 million in 2022 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2022 and 2023: Short term Debt plunged 98.95% in 2022, then soared 2486.44% in 2023.
- Over 5 years, Short term Debt stood at $7.1 million in 2021, then rose by 7.09% to $7.6 million in 2022, then tumbled by 80.04% to $1.5 million in 2023, then soared by 585.58% to $10.5 million in 2024, then slumped by 72.4% to $2.9 million in 2025.
- According to Business Quant data, Short term Debt over the past three periods registered $2.9 million, $10.5 million, and $10.4 million for Q3 2025, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.11 Bn | 59.92 Bn | 1.37 Bn |
| 4 | Moderna | 55.73 Bn | 50.59 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - |
| 10 | Serina Therapeutics | 44.24 Mn | 21.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.89 Mn |
| Sep 30, 2024 | 10.46 Mn |
| Jun 30, 2024 | 10.45 Mn |
| Mar 31, 2024 | 9.75 Mn |
| Sep 30, 2023 | 1.53 Mn |
| Jun 30, 2023 | 22.94 Mn |
| Mar 31, 2023 | 20.04 Mn |
| Dec 31, 2022 | 7.65 Mn |
| Sep 30, 2022 | 59,000.00 |
| Jun 30, 2022 | 6.97 Mn |
| Mar 31, 2022 | 6.66 Mn |
| Dec 31, 2021 | 7.14 Mn |
| Sep 30, 2021 | 5.60 Mn |
| Jun 30, 2021 | 3.56 Mn |
| Mar 31, 2021 | 2.02 Mn |
| Dec 31, 2020 | 1.96 Mn |
| Sep 30, 2020 | 435,000.00 |
| Jun 30, 2020 | 1.82 Mn |
| Mar 31, 2020 | 1.77 Mn |
| Dec 31, 2019 | 64,000.00 |